Redirecting immune, lipid, and metabolic drivers of early cardiovascular disease: the RESET cohort study and randomized trial

Eur Heart J. 2023 Oct 14;44(39):3939-3941. doi: 10.1093/eurheartj/ehad543.

Authors

Mayank Dalakoti^{1

2

3}, Roger Foo^{1

2}; RESET Consortium

Collaborators

RESET Consortium:
Roger Sik Yin Foo, Derek John Hausenloy, Chin Woon Loong Calvin, Mark Dhinesh Muthiah, Dennis Wang, Roshni Rebecca Singaraja, Josip Car, Wenru Wang, Mayank Dalakoti, Ching Hui Sia, Lohendran Baskaran, Melvin Khee Shing Leow, Yohanes Eko Riyanto, Paul A Macary, Han Wei Hou, Chester Lee Drum, Arthur Mark Richards, Jasper Tromp, Julian Savulescu, Nicholas Chew, Chrishan Julian Alles Ramachandran, Jason Kai Wei Lee, Wustefeld Torsten, Yibin Wang, Haojie Yu, Liang Zhong, Carolyn Lam Su Ping, Yan Yee Mark Chan, Yock Young Dan, Khung Keong Yeo, Tee Joo Yeo, Pierce Chow Kah Hoe, Dean Ho, Wei Jie Jonathan Lee, Poh Loong Soong, Lieng Hsi Ling, Tin Mei Yeo, Sebastian Maurer-Stroh, Tobias Leong, Mukkesh Kumar, Jamie Lye, Boxiang Liu

Affiliations

¹ National University Heart Centre, 5 Lower Kent Ridge Rd, Singapore 119074.
² Cardiovascular Metabolic Disease Translational Research Programme, National University of Singapore, MD6, Level 8, 14 Medical Drive, Singapore 117599.
³ Ng Teng Fong General Hospital, Singapore.

PMID: 37675563
DOI: 10.1093/eurheartj/ehad543

No abstract available

Grants and funding

National Medical Research Council Large Collaborative